A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma

There have been extensive efforts to improve the outcome of glioblastoma, but the prognosis of this disease has not been significantly altered to date. Histone deacetylase inhibitors (HDACIs) have been evaluated as promising anti-cancer drugs and regulate cell growth, cell cycle arrest and apoptosis...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Choi, Seung Ah, Kwak, Pil Ae, Park, Chul-Kee, Wang, Kyu-Chang, Phi, Ji Hoon, Lee, Ji Yeoun, Lee, Chang Sik, Lee, Ju-Hee, Kim, Seung-Ki
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354719/
https://ncbi.nlm.nih.gov/pubmed/27852054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13265
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky